glp 1 ag PDB-101: Molecule of the Month: GLP-1 Receptor Agonists History of glucagon-like peptide-1 receptor

Liu H, Dear AE, Knudsen LB, Simpson RW: A long-acting glucagon-like peptide-1 analogue attenuates induction of plasminogen activator inhibitor type-1 and vascular adhesion molecules

Nevertheless, DSP lacks organ or tissue targeting capabilities after oral or systemic administration, necessitating higher doses and more frequent administration to achieve effective concentrations at the inflammation site

& Korsmeyer, S.J

L.GrimsleyC.Kuttab-BoulosH.WitonskyD.KaszaK

Compounded GLP-1s may be cheaper, more available, can be tailored for custom mixtures, and with less restrictions on who can prescribe them

It is frequently studied with GLP-1 based compounds such as Semaglutide and Retatrutide in research environments